NEUPOGEN
- Product NDC
- 55513-546
- 11-digit product format
- 555130546
- Labeler code
- 55513
- Product ID
- 55513-546_7e2a1b99-5ac7-4803-9c39-bc4445dc7212
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Filgrastim
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Amgen, Inc
- Application
- BLA103353
- Marketing category
- BLA
- Marketing start
- 1997-04-07
- Substance
- FILGRASTIM
- Active strength
- 480 ug/1.6mL
- Pharmacologic classes
- Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NEUPOGEN
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FILGRASTIM | 480 ug/1.6mL |
Harmonized UNII identifiers#
UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| PVI5M0M1GW | Internal UNII lookup |
Harmonized SPL set identifiers#
SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55513-546-01 | NEUPOGEN | 1.6 mL in 1 VIAL | INJECTION, SOLUTION | 1.6 | | 164 |
| 55513-546-10 | NEUPOGEN | 10 in 1 BOX | INJECTION, SOLUTION | 10 | | 164 |
| 55513-546-20 | NEUPOGEN | 10 in 1 BOX | INJECTION, SOLUTION | 10 | | 164 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| FILGRASTIM, LICENSE HOLDER UNSPECIFIED | ACTIVE INGREDIENT | PVI5M0M1GW | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
| FILGRASTIM, LICENSE HOLDER UNSPECIFIED | ACTIVE MOIETY | PVI5M0M1GW | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55513-546 | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN, INC] | 162 | Current NDC, Legacy NDC, 3 package rows | 20250503_97cc73cc-b5b7-458a-a933-77b00523e193.zip |
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 103353 | Neupogen | filgrastim | 351(a) | Rx | 2026-10-01 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55513-546-01 | 55513054601 | 1.6 mL in 1 VIAL | 1.6 ml | | | | | Historical |
| 55513-546-10 | 55513054610 | 10 VIAL in 1 BOX (55513-546-10) / 1.6 mL in 1 VIAL (55513-546-01) | 10 vial | 1997-04-07 | 0000-00-00 | No | No | Current |
| 55513-546-20 | 55513054620 | 10 VIAL in 1 BOX (55513-546-20) / 1.6 mL in 1 VIAL (55513-546-01) | 10 vial | 2025-10-01 | | No | No | Current |